Northwestern Mutual Wealth Management Co. lifted its position in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 285,436.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,046,055 shares of the company’s stock after acquiring an additional 4,044,638 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in BlackRock Health Sciences Trust were worth $166,414,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Geneos Wealth Management Inc. lifted its holdings in shares of BlackRock Health Sciences Trust by 200.0% during the 2nd quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock worth $179,000 after acquiring an additional 3,266 shares during the period. Truist Financial Corp bought a new stake in shares of BlackRock Health Sciences Trust during the 3rd quarter worth approximately $205,000. Envestnet Asset Management Inc. bought a new stake in shares of BlackRock Health Sciences Trust during the 3rd quarter worth approximately $209,000. Oppenheimer & Co. Inc. lifted its holdings in shares of BlackRock Health Sciences Trust by 5.9% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 6,715 shares of the company’s stock worth $250,000 after acquiring an additional 373 shares during the period. Finally, Stratos Wealth Partners LTD. lifted its holdings in shares of BlackRock Health Sciences Trust by 11.5% during the 3rd quarter. Stratos Wealth Partners LTD. now owns 7,673 shares of the company’s stock worth $286,000 after acquiring an additional 790 shares during the period.
BlackRock Health Sciences Trust Stock Down 2.1%
Shares of BlackRock Health Sciences Trust stock opened at $38.80 on Friday. The company has a 50 day moving average of $39.39 and a 200-day moving average of $40.47. BlackRock Health Sciences Trust has a 1-year low of $35.03 and a 1-year high of $42.74.
BlackRock Health Sciences Trust Announces Dividend
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.
Further Reading
- Five stocks we like better than BlackRock Health Sciences Trust
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.
